Table 1
Clinical indication in female patients for CA125 measurement in the suspicion of malignancy category (n = 327)
| Indication | No of patients | Indication | No of patients |
|---|---|---|---|
| Abdominal pain | 116 | Liver metastases | 4 |
| Abnormal vaginal bleeding | 15 | Lung metastases | 1 |
| Altered bowel habit | 12 | Lymphadenopathy | 2 |
| Anaemia | 21 | Mediastinal mass | 2 |
| Back pain | 1 | Osteomyelitis | 1 |
| Bone metastases | 5 | Peripheral neuropathy | 3 |
| Bowel obstruction | 4 | Pleural effusion | 7 |
| Brain metastases | 5 | Polyarthritis | 4 |
| Collapse | 1 | Postmenopausal bleeding | 27 |
| Dermatomyositis | 10 | Rectal bleeding | 5 |
| Fracture | 1 | Rectovaginal fistula | 1 |
| Hyperkalaemia | 1 | Renal failure | 1 |
| Hypercalcaemia | 6 | Shortness of breath | 7 |
| Hypertension | 1 | Thromboembolic disease | 7 |
| Jaundice | 7 | Weight loss | 26 |
| Lethargy | 8 | Vaginal discharge | 2 |
| None stated | 13 |
